TECH & INNOVATIONThree institutions collaborate to develop vaccine to treat infection Three institutions collaborate to develop vaccine to treat infection The long-observed association between pneumonia and heart failure now has more physical evidence, thanks to research in the School of Medicine at The University of Texas Health Science Center at San Antonio.
A triple-punch of antibodies both prevented hepatitis C infection and wiped out the disease after it had established itself in laboratory mice, according to a study led by Princeton University researchers. Instead of delivering the three antibodies directly, the researchers administered a genetic "instruction set" that, once in a cell, developed into antibodies that target the portions of the virus that do not mutate.
Hispanics are often grouped into a single category when it comes to alcohol use. Yet a new Michigan State University study indicates that the risk of alcohol abuse and dependence can vary significantly among different subgroups within the population.
Gastric bypass surgery has better outcomes than gastric banding for long-term weight loss, controlling type 2 diabetes and high blood pressure, and lowering cholesterol levels, according to a new review by UT Southwestern Medical Center surgeons of nearly 30 long-term studies comparing the two types of bariatric procedures.
Yale researchers find that not all obese people feel better after such surgery Yale researchers find that not all obese people feel better after such surgery Most severely obese people experience much better spirits once they shed weight through a diet, lifestyle changes or medical intervention.
In a state famous for its turnpike and infamous for traffic, tolls and "Jersey drivers," a new partnership between the Rutgers-Eagleton Poll and Rutgers New Jersey Medical School (NJMS) has launched a series of public health polls with a survey about risky driving habits. New Jerseyans were asked about their perceptions of safety both as a driver and passenger.
Recently published prevalence estimates of neglected tropical diseases (NTDs) in five Latin American countries - Bolivia, Cuba, Ecuador, Nicaragua and Venezuela - could suggest a new direction for United States foreign policy in the region, according to a tropical-disease expert at Rice University's Baker Institute for Public Policy.
Documenting their findings in this week’s issue of the journal Nature, Virginia Tech geobiologist Shuhai Xiao and a team of researchers from the Chinese Academy of Sciences have found a multicellular fossil that predates the earliest of our known ancestors by nearly 60 million years; setting the evolutionary clock back quite a bit.
Pulling together the greatest resources in the world such as the NASA/ESA Hubble Space Telescope, the Spitzer Space Telescope and the Kepler Space Telescope, one team of international astronomers caught the break they were looking for when they discovered clear skies and more importantly water vapor on a planet 122 light years outside of our very own solar system.
St. Jude Children's Research Hospital study shows that adjusting treatment based on early response to chemotherapy boosts survival of young patients with Philadelphia chromosome-like acute lymphoblastic leukemia
Scientists at the U.S. Naval Research Laboratory (NRL) Materials Science and Technology Division have developed a novel one-step process using, for the first time in these types of syntheses, potassium superoxide (KO2) to rapidly form oxide nanoparticles from simple salt solutions in water.
The cost of monthly premiums for health insurance plans for Texans under the Affordable Care Act (ACA) can vary by hundreds of dollars, depending on a person's income and the level of coverage chosen, according to a report released today by the Episcopal Health Foundation and Rice University's Baker Institute for Public Policy.
UH biomedical engineer says such drug could eliminate traditional side effects UH biomedical engineer says such drug could eliminate traditional side effects New findings by a biomedical engineer and his team at the University of Houston (UH) raise hope for a new class of drugs to treat lupus that may not include the long list of adverse risks and side effects often associated with current treatments for this disease.